Why Marcus & Millichap Stock Is on Investors’ Radar

Marcus & Millichap (MMI) has drawn fresh attention after recent trading left the stock with a roughly 10% gain over the past month and about 17% over the past 3 months.

Against a latest share price of $31.21, Marcus & Millichap’s 7 day share price return of 8.33% and 90 day share price return of 17.38% contrast with a 1 year total shareholder return of 3.41% and 5 year total shareholder return that is down 9.40%. This suggests recent momentum has picked up after a much softer longer term experience for investors.

If you are comparing Marcus & Millichap with other opportunities in the market, this is a good moment to broaden your search and check out a screener of 20 top founder-led companies

With Marcus & Millichap now trading around $31.21 after a stretch of stronger short term returns but mixed longer term results, the key question is whether the current price underestimates its prospects or whether the market is already pricing in future growth.

Most Popular Narrative: 11.5% Overvalued

Marcus & Millichap is trading at $31.21, while the most followed narrative anchors fair value at $28.00. This sets up a clear valuation gap for investors to weigh.

The company's overreliance on transaction-driven revenue, especially with 82%-84% of revenue from real estate brokerage commissions, leaves Marcus & Millichap highly exposed to cyclical slowdowns in commercial real estate activity, potentially leading to material shocks to revenue and earnings in downturns.

Declines in average commission rates, especially as larger transaction volumes increase but come at lower fee percentages, signal growing fee compression and competitive pressure, which could continue to weigh on net margins and profitability over time.

Want to understand why this narrative still arrives at a higher fair value than today’s earnings profile suggests? The story leans heavily on future margin repair, double digit revenue expansion, and a different earnings multiple several years out. Curious which specific financial milestones need to line up for that $28.00 outcome.

Result: Fair Value of $28 (OVERVALUED)

However, if market activity cools, Marcus & Millichap’s heavy reliance on transaction commissions and fee pressure from lower commission rates could quickly challenge the optimistic narrative.

Another View on Marcus & Millichap’s Valuation

The narrative based on future earnings points to Marcus & Millichap being 11.5% overvalued at $31.21 versus a $28.00 fair value. However, the current P/S of 1.5x looks low compared with the US Real Estate industry at 2.7x and peers at 0.5x. The fair ratio of 0.8x suggests the market could still reset closer to that level. How comfortable are you with that valuation gap if sentiment turns?

To stress test your own view against these ratios, it can help to walk through the full valuation breakdown in detail, right down to the assumptions behind each multiple, in the See what the numbers say about this price — find out in our valuation breakdown..

Next Steps

Seeing both the concerns and the optimism around Marcus & Millichap, do you want to rely on others or test the story yourself? Act now and review the data on risks and potential upside, then ground your view in the full picture with the 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond Marcus & Millichap?

If Marcus & Millichap has you thinking more broadly about opportunities, do not stop here. The right mix of stocks often starts with a wider search.

• Target income first by scanning companies that aim to sustain higher yields with the 9 dividend fortresses.
• Hunt for potential value opportunities that combine quality fundamentals with attractive pricing through the 42 high quality undervalued stocks.
• Prioritise financial strength by focusing on companies that carry less balance sheet strain using the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.